Sam Brusco, Associate Editor02.13.24
Zeda, a global technology solutions company, has acquired The Orthopaedic Implant Company (OIC), a leader in value-based implants.
OIC is a pioneer in delivering high-quality, cost-effective orthopedic devices. Zeda said the acquisition enables the company to produce OIC’s implant designs, accelerating its mission to offer accessible, high-value trauma implants to patients worldwide.
Under the acquisition deal’s terms, OIC will operate as a Zeda Health company. It solidifies Zeda's position in the global orthopedic industry as a firm developing and using leading design and manufacturing technologies that push device design forward while drastically improving affordability and access to excellent care.
Shri Shetty, CEO of Zeda, said, "The acquisition of OIC represents a pivotal moment for Zeda. Its leadership in value-based implants perfectly complements our additive manufacturing technologies that can deliver high quality orthopedic devices and implants that are accessible to all patients, regardless of country and socioeconomic status. Together, our strengths and expertise will raise the standard of care globally and equitably for the world’s entire population."
Itai Nemovicher, CEO and co-founder of OIC, added, "We are proud to join forces with Zeda, a company that shares in our values and dedication to advancing access to critical orthopedic care because it can and should be done. Under Zeda, OIC will reach new heights in providing cost-effective, high-quality orthopedic solutions in the US and abroad."
OIC is a pioneer in delivering high-quality, cost-effective orthopedic devices. Zeda said the acquisition enables the company to produce OIC’s implant designs, accelerating its mission to offer accessible, high-value trauma implants to patients worldwide.
Under the acquisition deal’s terms, OIC will operate as a Zeda Health company. It solidifies Zeda's position in the global orthopedic industry as a firm developing and using leading design and manufacturing technologies that push device design forward while drastically improving affordability and access to excellent care.
Shri Shetty, CEO of Zeda, said, "The acquisition of OIC represents a pivotal moment for Zeda. Its leadership in value-based implants perfectly complements our additive manufacturing technologies that can deliver high quality orthopedic devices and implants that are accessible to all patients, regardless of country and socioeconomic status. Together, our strengths and expertise will raise the standard of care globally and equitably for the world’s entire population."
Itai Nemovicher, CEO and co-founder of OIC, added, "We are proud to join forces with Zeda, a company that shares in our values and dedication to advancing access to critical orthopedic care because it can and should be done. Under Zeda, OIC will reach new heights in providing cost-effective, high-quality orthopedic solutions in the US and abroad."